| ²é¿´: 446 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
sniclÒø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
¼òµ¥¾ä·ÒëÓ´£¬³¬¼òµ¥
|
|
|
COPDÎȶ¨ÆÚ¼°COPD¼±ÐÔ¼ÓÖØÆÚ£¬NNPŨ¶ÈµÄROCÇúÏßÏÂÃæ»ý¾ù³¬¹ý0.9£¬¾ßÓкܸߵÄÕï¶Ï׼ȷ¶È¡£ ÂýÐÔ×èÈûÐԷμ²²¡Ä¿Ç°Ö÷ÒªÒÀ¿¿·Î¹¦Äܼì²éÀ´Õï¶Ï£¬ÉÐÎÞÒ»ÖÖ½ÏΪÃô¸ÐµÄѪÇå±ê¼ÇÎï¡£ ÒÔÉÏ·Òë³ÉÓ¢Ó¶¼ÊǼòµ¥¾ä¡£ÎÒ×Ô¼º·ÒëµÄ£¬ÀÏÊǺͱðÈ˵ķÒëÖØÁË£¬Çë´ó¼Ò°ïÎÒ·Òëһϣ¬½µµÍÏàËÆ¶È |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ר˶304ÕÒµ÷¼Á£¬Ò»Ïß³ÇÊÐ×îºÃ
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸ÄϺ½£¬ÊýһӢһѧ˶317Çóµ÷¼Á£¡£¡
ÒѾÓÐ6È˻ظ´
295Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ12È˻ظ´
0703»¯Ñ§µ÷¼Á325·Ö
ÒѾÓÐ13È˻ظ´
08600ÉúÎïÓëÒ½Ò©-327
ÒѾÓÐ8È˻ظ´
µ÷¼Á
ÒѾÓÐ10È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ15È˻ظ´

RXMCDM
°æÖ÷ (ÎÄ̳¾«Ó¢)
- ·ÒëEPI: 530
- Ó¦Öú: 401 (˶ʿ)
- ¹ó±ö: 1.908
- ½ð±Ò: 38947.6
- É¢½ð: 4908
- ºì»¨: 88
- ɳ·¢: 4
- Ìû×Ó: 11453
- ÔÚÏß: 1355.6Сʱ
- ³æºÅ: 2739168
- ×¢²á: 2013-10-20
- ÐÔ±ð: GG
- רҵ: Ò»°ã¹ÜÀíÀíÂÛÓëÑо¿·½·¨ÂÛ
- ¹ÜϽ: ÂÛÎÄ·Òë
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
snicl: ½ð±Ò+10, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ¸Ðл¸Ðл£¬°æÖ÷Ç¿´ó 2014-03-06 23:11:29
snicl: ½ð±Ò+10, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ¸Ðл¸Ðл£¬°æÖ÷Ç¿´ó 2014-03-06 23:11:29
|
COPDÎȶ¨ÆÚ¼°COPD¼±ÐÔ¼ÓÖØÆÚ£¬NNPŨ¶ÈµÄROCÇúÏßÏÂÃæ»ý¾ù³¬¹ý0.9£¬¾ßÓкܸߵÄÕï¶Ï׼ȷ¶È¡£ The NNP concentrations of all COPD stabilization period and acute exacerbation phase patients in terms of the area under the ROC curve were more than 0.9 and had a high COPD diagnostic accuracy. ÂýÐÔ×èÈûÐԷμ²²¡Ä¿Ç°Ö÷ÒªÒÀ¿¿·Î¹¦Äܼì²éÀ´Õï¶Ï£¬ÉÐÎÞÒ»ÖÖ½ÏΪÃô¸ÐµÄѪÇå±ê¼ÇÎï¡£ Without any sensitive serum markers,the diagnosis of chronic obstructive pulmonary disease currently relied mainly on pulmonary function tests |

2Â¥2014-03-06 23:04:17














»Ø¸´´ËÂ¥